Identified Gefitinib Metabolism-Related lncRNAs can be Applied to Predict Prognosis, Tumor Microenvironment, and Drug Sensitivity in Non-Small Cell Lung Cancer

Gefitinib has shown promising efficacy in the treatment of patients with locally advanced or metastatic EGFR-mutated non-small cell lung cancer (NSCLC). Molecular biomarkers for gefitinib metabolism-related lncRNAs have not yet been elucidated. Here, we downloaded relevant genes and matched them to...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Weilong, Wu, Zhengguo, Gao, Pengbo, Kang, Jianhao, Xu, Yue, Wei, Chuzhong, Zhang, Ming, Zhu, Xiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9376789/
https://www.ncbi.nlm.nih.gov/pubmed/35978819
http://dx.doi.org/10.3389/fonc.2022.939021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9376789/
https://www.ncbi.nlm.nih.gov/pubmed/35978819
http://dx.doi.org/10.3389/fonc.2022.939021

Ejemplares similares